Observe Medical ASA (OSL:OBSRV)
Norway · Delayed Price · Currency is NOK 0.9800
-0.0180 (-1.80%)
At close: Aug 26, 2026
Observe Medical ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21.91 | 18.81 | 17.23 | 27.94 | 19.52 | 24.04 | |
Revenue Growth | 32.16% | 9.18% | -38.34% | 43.14% | -18.80% | 711.96% |
Cost of Revenue | 15.92 | 14.11 | 15.41 | 18.66 | 14.34 | 14.52 |
Gross Profit | 5.99 | 4.7 | 1.82 | 9.29 | 5.18 | 9.52 |
Selling, General & Admin | 16.69 | 14.71 | 15.29 | 24.22 | 27.31 | 17.26 |
Other Operating Expenses | 13.06 | 16.26 | 16.55 | 28.02 | 26.08 | 20.72 |
Operating Expenses | 38.47 | 44.29 | 46.22 | 66.39 | 64.32 | 41.44 |
Operating Income | -32.48 | -39.59 | -44.4 | -57.1 | -59.14 | -31.93 |
Interest Expense | -3.44 | -5.17 | -9.55 | -6.65 | -3.82 | -3.33 |
Interest & Investment Income | 0.01 | 0 | 1.78 | 0.06 | 0.28 | - |
Currency Exchange Gain (Loss) | 1.8 | 3.46 | -5.42 | -4.28 | 1.64 | 4.64 |
Other Non Operating Income (Expenses) | 39.04 | 39.04 | -0.02 | -1.82 | 0.65 | -0.43 |
EBT Excluding Unusual Items | 4.93 | -2.27 | -57.61 | -69.78 | -60.39 | -31.04 |
Merger & Restructuring Charges | -2.01 | - | - | - | - | -4.62 |
Impairment of Goodwill | -37.69 | -41.73 | -2.68 | -67.11 | - | - |
Other Unusual Items | -7.5 | -4.65 | 1.56 | 1.81 | 9.67 | 9.34 |
Pretax Income | -24.03 | -48.64 | -58.73 | -135.08 | -50.73 | -26.32 |
Income Tax Expense | - | - | - | 0.02 | 0.08 | - |
Net Income | -24.03 | -48.64 | -58.73 | -135.1 | -50.8 | -26.32 |
Net Income to Common | -24.03 | -48.64 | -58.73 | -135.1 | -50.8 | -26.32 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 127 | 67 | 15 | 4 | 3 | 1 |
Shares Outstanding (Diluted) | 127 | 67 | 15 | 4 | 3 | 1 |
Shares Change | 604.68% | 348.57% | 287.07% | 22.13% | 140.67% | 18.29% |
EPS (Basic) | -0.19 | -0.73 | -3.95 | -35.17 | -16.15 | -20.14 |
EPS (Diluted) | -0.19 | -0.73 | -3.95 | -35.17 | -16.20 | -20.14 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -43.27 | -25.97 | -29.27 | -32.47 | -52.74 | -22.34 |
Free Cash Flow Per Share | -0.34 | -0.39 | -1.97 | -8.45 | -16.77 | -17.09 |
Gross Margin | 27.34% | 24.98% | 10.56% | 33.24% | 26.52% | 39.59% |
Operating Margin | -148.23% | -210.48% | -257.69% | -204.36% | -302.97% | -132.79% |
Profit Margin | -109.68% | -258.57% | -340.86% | -483.50% | -260.24% | -109.48% |
Free Cash Flow Margin | -197.50% | -138.07% | -169.91% | -116.21% | -270.16% | -92.94% |
EBITDA | -27.33 | -28.62 | -32.56 | -46.82 | -51.61 | -31.11 |
EBITDA Margin | -124.75% | -152.17% | -189.00% | -167.56% | -264.36% | -129.38% |
D&A For EBITDA | 5.14 | 10.97 | 11.84 | 10.28 | 7.54 | 0.82 |
EBIT | -32.48 | -39.59 | -44.4 | -57.1 | -59.14 | -31.93 |
EBIT Margin | -148.23% | -210.48% | -257.69% | -204.36% | - | -132.79% |
Advertising Expenses | - | 0.02 | 0.14 | 0.11 | 0.3 | 0.7 |